Accelerate to discover

Back to filter

Related topics

Webinar recording: Isolating ultra-high molecular weight (UHMW) DNA for genome analysis

BioNano Genomics

May 12, 2020

Watch the webinar from Bionano Genomics and learn the tips and tricks for isolating high quality UHMW DNA - right from...

Isoflux webinar: Accurate liquid biopsy approach reveals mutations in lung cancer patients

Fluxion Biosciences

Apr 29, 2020

Liquid biopsies aim to identify clinically actionable information from cell-free DNA (cfDNA) and circulating tumor...

Panel design principles to investigate COVID-19 immune response with the Cytek Aurora

Cytek Biosciences

Apr 27, 2020

Learn about the Cytek Aurora and panel design tools available to help you design high quality full spectrum cytometry...

Ensuring Quantitative Accuracy in PET webinar

Bruker Biospin

Apr 14, 2020

Image quality is only one aspect of functional imaging with PET and SPECT and the ability to reproducibly extract...

May 26, 2020

xCELLigence system: rapid and sensitive, ideal for infectious viral assays.

Acea Biosciences

Mar 30, 2020

As the public health threat from COVID-19 and future emergent viruses continue to persist, the rapid, sensitive, and...

IncuCyte webinar: Organoids, iPSCs, and advanced cell models.

Sartorius

Mar 24, 2020

Researchers are now moving from reductionist, 2D monoculture assay models to more complex 3D cell models, such as...

Webinar recording: Metabolic MR Imaging of Obesity

Bruker Biospin

Mar 24, 2020

The study of fat distribution is important to understand the pathophysiology of obesity related disorders, diabetes...

May 26, 2020

Webinar recording: Ex vivo microangioCT, advances in microvascular imaging

Bruker Biospin

Mar 16, 2020

A new technique called microangioCT imaging is being used with a novel polymerizing contrast agent that enables 3D...

Show all topics (10)

Monitoring cancer treatments with immuno-PET webinar

Mar 8, 2019

The clinical use of full-length mAbs as imaging agents can be challenging, due to their long biological half-life and relatively slow tumor penetration, which may affect tumor-to-background contrast at early time points. To circumvent these issues, Dr Gabriela Kramer-Marek’s team has developed radiolabeled affibody-based PET tracers that still have high specificity and affinity of the potential therapeutic mAb, but their molecular weight below 60 kDa allows for rapid renal clearance and elimination. In this webinar, Dr Gabriela Kramer-Marek will focus on HER-specific imaging radioconjugates that could provide unique information as cancer biomarkers, including quantification of receptor heterogeneity and early detection of changes in target expression in response to therapy.

Dr Ali Asgar Attarwala, Bruker BioSpin and Dr Gabriela Kramer-Marek, Team Leader Preclinical Molecular Imaging, The Institute of Cancer Research London 

Register Now

Webinar

Related technologies: PET, SPECT, CT

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 255 700 886

Send Message

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

Albira combines PET, SPECT and CT imaging in a unique and extremely powerful way

show detail

High Performance Total Body PET and CT for mice & rats with fast scan times with unparalleled quality

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey